What is the optimal timing for performing an aldosterone‑renin ratio (ARR) screening test?

Optimal Timing for Aldosterone-Renin Ratio Screening

The aldosterone-renin ratio (ARR) should be measured in the morning (after being awake for at least 2 hours) with the patient seated for 5-15 minutes following several days of unrestricted salt intake (minimum 5 g/day NaCl). 1, 2

Key Timing and Positioning Requirements

Time of Day and Posture

• Morning measurement is essential after the patient has been awake for more than 2 hours 2
• Seated position for 5-15 minutes before blood draw 1, 2
• The upright posture improves sensitivity compared to supine positioning 3, 4

Research demonstrates that ARR cutoff levels vary significantly based on posture and time of day, ranging from 13.1-35.0 ng/dL per ng/mL/h depending on these conditions 3. One study found that ARR measured after 2-hour upright posture had superior diagnostic accuracy (AUCROC 0.980) compared to supine position (AUCROC 0.962) 4.

Pre-Test Dietary Preparation

• Liberal salt intake for several days prior to testing (minimum 5 g/day NaCl) 1, 2
• Avoid dietary sodium restriction, as this can stimulate renin and cause false-negative results 1, 5

Critical Pre-Test Conditions

Potassium Correction

Hypokalemia must be corrected before testing as low potassium potently inhibits aldosterone secretion and causes false-negatives 1, 2, 5:

• Target serum potassium ≥4 mmol/L 2
• Use potassium chloride (KCl) for supplementation
• Avoid potassium bicarbonate-containing supplements 2
• If initial screen is negative with hypokalemia present, correct potassium and repeat testing 1

Sample Collection Technique

• Extract blood slowly to prevent venous stasis and hemolysis 2
• Keep samples at room temperature (not on ice) to prevent in vitro conversion of prorenin to active renin 2
• Centrifuge within 30 minutes of collection 1, 2
• For accurate potassium measurement: use syringe and needle, avoid fist clenching, wait ≥5 seconds after tourniquet release 1

Medication Management Strategy

The 2025 Endocrine Society guideline offers flexibility regarding medication withdrawal 1:

Minimal-Withdrawal Approach (Preferred for Initial Screening)

Screening can be performed without stopping most antihypertensives initially, which facilitates increased screening 1, 2. However:

• Avoid testing while on diuretics and mineralocorticoid receptor antagonists (MRAs) if possible 2
• Recent evidence shows ARR before washout maintains high diagnostic accuracy, particularly in patients on RAS inhibitors 6, 7

Medications Requiring Withdrawal (If Safe and Feasible)

For 4 weeks before testing:

• MRAs (spironolactone, eplerenone)
• ENaC inhibitors (amiloride, triamterene)
• Other diuretics 1, 2

For 2 weeks before testing:

• ACE inhibitors and ARBs (raise renin, may cause false-negatives) 1, 2
• β-blockers and α2-agonists (lower renin, may cause false-positives) 1, 5

Acceptable Medications During Testing

• α1-blockers (doxazosin, prazosin)
• Hydralazine
• Long-acting verapamil or diltiazem (non-dihydropyridine calcium channel blockers) 1, 2

Common Pitfalls and Special Considerations

False-Positive Risk Factors

• β-blockers and centrally acting α2-agonists suppress renin 1, 5
• Age ≥65 years: physiological renin reduction can elevate ARR 2
• Chronic kidney disease: reduced renin with less aldosterone involvement 2
• Premenopausal women in luteal phase: higher ARR, particularly with direct renin concentration (not plasma renin activity) 2, 5

False-Negative Risk Factors

• Uncorrected hypokalemia 1, 5
• Dietary salt restriction 5
• Diuretics, ACE inhibitors, ARBs 1, 5
• Pregnancy (both hormones rise, renin more so) 2
• Concomitant malignant or renovascular hypertension 5

When to Repeat Testing

Repeat ARR on a different day if 1:

• Initial screen negative with hypokalemia or interfering medications present
• Initial screen negative but moderate-to-high pretest probability (resistant hypertension, hypokalemia)
• Initial screen negative but renin suppressed with aldosterone 5-10 ng/dL (138-277 pmol/L)
• Initial screen positive but patient on β-blockers or α2-agonists

Age-Specific Considerations

Recent research suggests age-specific ARR cutoffs may improve diagnostic accuracy, with higher thresholds needed in older patients (cutoff 2.4 for age <50 years vs. 3.7 for age ≥50 years) 8. However, the 2025 guideline emphasizes that PA patients maintain similar aldosterone and renin levels regardless of age over 65 2.